In non-small cell lung cancer (NSCLC) patients proliferation of peripheral blood CD8+T after PD-1-targeted therapy occur only in cells expressing PD-1, and this cells subpopulation is high in responding patients [39]. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.